Jasper Therapeutics (JSPR) Revenue & Revenue Breakdown
Jasper Therapeutics Revenue Highlights
00
Jasper Therapeutics Revenue by Period
Jasper Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Jasper Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $2.05M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Jasper Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EQ | Equillium | $36.08M | $12.16M |
HOOK | HOOKIPA Pharma | $20.13M | - |
IKNA | Ikena Oncology | $9.16M | - |
INBX | Inhibrx Biosciences | $1.80M | - |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
DSGN | Design Therapeutics | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
EPIX | ESSA Pharma | - | - |
ORIC | ORIC Pharmaceuticals | - | - |
EWTX | Edgewise Therapeutics | - | - |
JSPR | Jasper Therapeutics | - | - |
XLO | Xilio Therapeutics | - | $2.36M |
ELDN | Eledon Pharmaceuticals | - | - |